Françoise Bono
Corporate Officer/Principal at OSE IMMUNOTHERAPEUTICS
Profile
Françoise Bono is currently the Senior Director-Strategic Development at OSE Immunotherapeutics SA since 2021.
Prior to this, she worked as the Chief Scientific Officer at Valerio Therapeutics SA from 2017 to 2020 and as the Executive Vice President-Oncology at Evotec (France) SAS from 2015 to 2016.
Dr. Bono holds a doctorate degree from Institut d'Administration Des Entreprises De Toulouse.
Françoise Bono active positions
| Companies | Position | Start |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | 2021-12-19 |
Former positions of Françoise Bono
| Companies | Position | End |
|---|---|---|
| VALERIO THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2020-10-31 |
Evotec (France) SAS
 Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Corporate Officer/Principal | 2016-10-31 |
Training of Françoise Bono
| Institut d'Administration Des Entreprises De Toulouse | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VALERIO THERAPEUTICS | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 1 |
|---|---|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Commercial Services |
- Stock Market
- Insiders
- Françoise Bono
